| MNC Pharma shares from BSE & NSE | 20Mar20 Chart Strength |
6Dec19 Chart Strength |
9Sep19 Chart Strength |
12Sep18 Chart Strength |
4Jun18 Chart Strength |
17Jan18 Chart Strength |
7Aug15 Chart Strength |
| Abbott India | 1 strongest | 1* strongest | 1* strongest | 2 | 2 | 3 | 5 |
| Astrazeneca Pharma India | 3 | 4* | 3* | 6 | 5 | 5 | 6 |
| GlaxoSmithKline Pharmaceuticals | 6 | 3* | 5 | 4 | 7 | 7 | 4 |
| Novartis India | 7 | 7 | 7 | 5 | 6 | 6 | 2 |
| Pfizer | 2 | 2* | 4* | 3 | 1 strongest | 1 strongest | 3 |
| Procter & Gamble Health (Merck) | 5 | 6 | 6 | 7 | 3 | 2 | 7 |
| Sanofi India | 4 | 5* | 2* | 1 strongest | 4 | 4 | 1 strongest |
| Above 200-dma | 43% | 86% | 86% | 100% | 100% | 100% | 100% |
Note *Trading above 50/200-dma golden crossover
These are some leading MNC Pharmaceutical companies listed and traded in India.
- Stocks trading above 200 day moving average
Shares are shown in blue colour - Stocks trading below but close to 200 day moving average
Shares are shown in orange colour - Stocks trading much below 200 day moving average
Shares are shown in red colour
Technical Trend of MNC Pharma stocks
Out of the 7 MNC Pharma stocks 3 are trading above 200 day moving average.
That means 43% of MNC Pharmaceutical stocks are trading above 200-dma.
Pfizer, Roche and Novartis lost their patent cases in India.
MNC Pharma shares outperform the market most of the time.
Outperformers: Abbott India, Pfizer, AstraZeneca Pharma.
Underperformers: Novartis India, GlaxoSmithKline Pharma.
Related topics
Health Care or Pharma
Pharmaceutical – NSE
Pharmaceutical – Others
Multinational Company – NSE